Actively Recruiting
A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy
Led by AstraZeneca · Updated on 2026-05-12
335
Participants Needed
28
Research Sites
158 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is an observational, multicenter, prospective study on patients with severe eosinophilic asthma treated with benralizumab aimed at evaluating the achievement of partial and complete clinical remission.
CONDITIONS
Official Title
A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults (18 years or older) diagnosed with severe uncontrolled eosinophilic asthma
- Benralizumab prescribed according to approved label and local reimbursement rules
- Signed informed consent provided before study activities
- Benralizumab started within 7 days before enrollment or planned to start within 7 days after enrollment with prior prescription decision
You will not qualify if you...
- Benralizumab treatment within 12 months before enrollment and up to 8 days before enrollment
- Participation in any other clinical trial within 12 months before enrollment or planned participation during follow-up
- Contraindication to benralizumab according to current prescribing information
- Pregnant or breastfeeding women
- Any clinical condition affecting ability to cooperate or comply with study procedures
- Previous or current use of omalizumab, reslizumab, dupilumab, tezepelumab, or mepolizumab without appropriate washout
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 28 locations
1
Research Site
Salerno, Battipaglia, Italy, 84031
Not Yet Recruiting
2
Research Site
Padova, Cittadella, Italy, 35013
Not Yet Recruiting
3
Research Site
Teramo, Giulianova, Italy, 64021
Actively Recruiting
4
Research Site
Treviso, Montebelluna, Italy, 31044
Actively Recruiting
5
Research Site
Varese, Tradate, Italy, 21049
Actively Recruiting
6
Research Site
Bari, Italy, 70120
Actively Recruiting
7
Research Site
Bergamo, Italy, 24127
Not Yet Recruiting
8
Research Site
Bologna, Italy, 40138
Actively Recruiting
9
Research Site
Bologna, Italy, 40139
Not Yet Recruiting
10
Research Site
Brescia, Italy, 25123
Not Yet Recruiting
11
Research Site
Catania, Italy, 95123
Not Yet Recruiting
12
Research Site
Catanzaro, Italy, 88100
Actively Recruiting
13
Research Site
Florence, Italy, 50134
Not Yet Recruiting
14
Research Site
Foggia, Italy, 71122
Not Yet Recruiting
15
Research Site
Messina, Italy, 98124
Not Yet Recruiting
16
Research Site
Milan, Italy, 20142
Actively Recruiting
17
Research Site
Modena, Italy, 41125
Actively Recruiting
18
Research Site
Naples, Italy, 80131
Actively Recruiting
19
Research Site
Naples, Italy, 80131
Not Yet Recruiting
20
Research Site
Padova, Italy, 35128
Not Yet Recruiting
21
Research Site
Palermo, Italy, 90127
Actively Recruiting
22
Research Site
Pavia, Italy, 27100
Not Yet Recruiting
23
Research Site
Roma, Italy, 00152
Not Yet Recruiting
24
Research Site
Roma, Italy, 00189
Actively Recruiting
25
Research Site
Sassari, Italy, 07100
Not Yet Recruiting
26
Research Site
Siena, Italy, 53100
Not Yet Recruiting
27
Research Site
Torino, Italy, 10128
Actively Recruiting
28
Research Site
Verona, Italy, 37134
Not Yet Recruiting
Research Team
A
AstraZeneca Clinical Study Information Center
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here